Literature DB >> 22419440

Analysis of molecular cytogenetic alterations in uterine leiomyosarcoma by array-based comparative genomic hybridization.

Mohammad Raish1, Mohsin Khurshid, Mushtaq Ahmad Ansari, Pankaj Kumar Chaturvedi, Su-Mi Bae, Jang Heub Kim, Eun Kyung Park, Dong Chun Park, Woong Shick Ahn.   

Abstract

OBJECTIVE: The aim of this study was to identify novel genes following genomic DNA copy number changes using a genome-wide array-based comparative genomic hybridization (array-CGH) analysis in uterine leiomyosarcoma (ULMS).
METHODS: Genomic DNA copy number changes were analyzed in 15 cases of ULMS from St Mary's Hospital of the Catholic University of Korea. The paraffin-fixed tissue samples were micro-dissected under microscope, and DNA was extracted. Array-based CGH and genomic polymerase chain reaction were carried out with statistical analyses such as hierarchical clustering and Gene Ontology.
RESULTS: All of 15 cases of ULMS showed specific gains and losses. The percentage of average gains and losses were 8.4 and 16.6 %, respectively. The analysis limit of average gains and losses was 40 %. The regions of high level of gain were 1q23.3, 7p14.2, 7q34, 7q35, 7q36.3, 13q34, and 16p13.3. And the regions of homozygous loss were 2q21.1, 2q22.1, 2p23.2, 12q23.3, 4q21.22, 4q34.3, 11q24.2, 12q23.3, 13q13.1, 13q21.33, and 14q24.3. In ULMS samples, recurrent regions of gain were 1p36.33, 1p36.32, 5q35.3, 7q36.3, and 8q24.3 and recurrent regions of loss were 1p31.1-p31.3, 1p32.1-p32.3, 2p12, 2p13.3, 2p14, 2p16.2-p16.3, 2q12.1-q12.3, 2q21.1-q21.2, 2q22.2-q22.3, 2q34, 2q36.1-q36.3, 5q21.3, 5q23.3, 5q31.1, 6p11.2, 6p12.1, 10q11.23, 10q21.2-q21.3, 10q23.2, 10q23.31, 10q25.1-q25.2, 10q25.3, 10q26.13, 10q26.2-q26.3, 11p11.2, 11p11.12, 11p12, 11p13, 11p15.4, 11q23.1-q23.2, 11q23.3, 13q14.12, 13q14.13-13q14.2, 13q14.2, 13q14.2, 13q14.3, 13q21.33, 13q22.1-q22.3, 14q24.2, 14q24.3, 14q31.1, 14q32.33, 15q11.2-q13, 15q14, 16q22.3, 16q23.1, 16q23.2, 16q24.1, 20p12.1, and 21q22.3. Representative frequently gained BAC clones encoded genes were HDAC9, CRR9, SOX18, PTPRN2, SKI, SOLH, and KIAA1199. The genes encoded by frequently lost BAC clones were LOC150516 and AMY2A. A subset of cellular processes from each gene were clustered by Gene Ontology database.
CONCLUSIONS: The present study using array-CGH analyses sought a deeper elucidation of the specific genomic alterations related to ULMS. The high resolution of array-CGH combined with human genome database would give a chance at identifying relevant target genes.

Entities:  

Mesh:

Year:  2012        PMID: 22419440     DOI: 10.1007/s00432-012-1182-6

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  28 in total

1.  Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene.

Authors:  D G Albertson; B Ylstra; R Segraves; C Collins; S H Dairkee; D Kowbel; W L Kuo; J W Gray; D Pinkel
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.

Authors:  Li-Sung Hsu; Hsin-Chen Lee; Gar-Yang Chau; Pen-Hui Yin; Chin-Wen Chi; Wing Yiu Lui
Journal:  Oncol Rep       Date:  2006-02       Impact factor: 3.906

3.  Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances.

Authors:  S Solinas-Toldo; S Lampel; S Stilgenbauer; J Nickolenko; A Benner; H Döhner; T Cremer; P Lichter
Journal:  Genes Chromosomes Cancer       Date:  1997-12       Impact factor: 5.006

4.  Consistent chromosome changes in leiomyosarcoma.

Authors:  S N Sait; P Dal Cin; A A Sandberg
Journal:  Cancer Genet Cytogenet       Date:  1988-10-01

5.  DNA copy number changes in development and progression in leiomyosarcomas of soft tissues.

Authors:  W El-Rifai; M Sarlomo-Rikala; S Knuutila; M Miettinen
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

6.  Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.

Authors:  B J Quade; A P Pinto; D R Howard; W A Peters; C P Crum
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

7.  Genomic segmental polymorphisms in inbred mouse strains.

Authors:  Jiangzhen Li; Tao Jiang; Jian-Hua Mao; Allan Balmain; Leif Peterson; Charles Harris; Pulivarthi H Rao; Paul Havlak; Richard Gibbs; Wei-Wen Cai
Journal:  Nat Genet       Date:  2004-08-22       Impact factor: 38.330

8.  Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains.

Authors:  H R Ashar; M S Fejzo; A Tkachenko; X Zhou; J A Fletcher; S Weremowicz; C C Morton; K Chada
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

9.  High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays.

Authors:  D Pinkel; R Segraves; D Sudar; S Clark; I Poole; D Kowbel; C Collins; W L Kuo; C Chen; Y Zhai; S H Dairkee; B M Ljung; J W Gray; D G Albertson
Journal:  Nat Genet       Date:  1998-10       Impact factor: 38.330

10.  Chromosomal abnormalities in leiomyosarcomas.

Authors:  C Sreekantaiah; J R Davis; A A Sandberg
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

View more
  16 in total

1.  Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions.

Authors:  Sabrina Croce; Agnes Ribeiro; Celine Brulard; Jean-Christophe Noel; Frederic Amant; Eberhard Stoeckle; Mojgan Devouassoux-Shisheborah; Anne Floquet; Laurent Arnould; Frederic Guyon; Florence Mishellany; Delphine Garbay; Tine Cuppens; Michal Zikan; Agnès Leroux; Eric Frouin; Pierre Duvillard; Philippe Terrier; Isabelle Farre; Isabelle Valo; Gaetan M MacGrogan; Frederic Chibon
Journal:  Mod Pathol       Date:  2015-05-01       Impact factor: 7.842

2.  Somatic amplifications and deletions in genome of papillary thyroid carcinomas.

Authors:  Nadia Passon; Elisa Bregant; Marialuisa Sponziello; Maria Dima; Francesca Rosignolo; Cosimo Durante; Marilena Celano; Diego Russo; Sebastiano Filetti; Giuseppe Damante
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

3.  Gene expression signatures of primary and metastatic uterine leiomyosarcoma.

Authors:  Ben Davidson; Vera Maria Abeler; Mette Førsund; Arild Holth; Yanqin Yang; Yusuke Kobayashi; Lily Chen; Gunnar B Kristensen; Ie-Ming Shih; Tian-Li Wang
Journal:  Hum Pathol       Date:  2013-11-13       Impact factor: 3.466

4.  Genome-wide association study identifies possible genetic risk factors for colorectal adenomas.

Authors:  Todd L Edwards; Martha J Shrubsole; Qiuyin Cai; Guoliang Li; Qi Dai; Douglas K Rex; Thomas M Ulbright; Zhenming Fu; Ryan H Delahanty; Harvey J Murff; Walter Smalley; Reid M Ness; Wei Zheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-05-15       Impact factor: 4.254

Review 5.  Resistance to Immune Checkpoint Blockade in Uterine Leiomyosarcoma: What Can We Learn from Other Cancer Types?

Authors:  Wout De Wispelaere; Daniela Annibali; Sandra Tuyaerts; Diether Lambrechts; Frédéric Amant
Journal:  Cancers (Basel)       Date:  2021-04-23       Impact factor: 6.639

6.  Genome-wide copy number variation in sporadic amyotrophic lateral sclerosis in the Turkish population: deletion of EPHA3 is a possible protective factor.

Authors:  Özgün Uyan; Özgür Ömür; Zeynep Sena Ağım; Aslıhan Özoğuz; Hong Li; Yeşim Parman; Feza Deymeer; Piraye Oflazer; Filiz Koç; Ersin Tan; Hilmi Özçelik; A Nazlı Başak
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

7.  Genomic, Epigenomic, and Transcriptomic Profiling towards Identifying Omics Features and Specific Biomarkers That Distinguish Uterine Leiomyosarcoma and Leiomyoma at Molecular Levels.

Authors:  Tomoko Miyata; Kenzo Sonoda; Junko Tomikawa; Chiharu Tayama; Kohji Okamura; Kayoko Maehara; Hiroaki Kobayashi; Norio Wake; Kiyoko Kato; Kenichiro Hata; Kazuhiko Nakabayashi
Journal:  Sarcoma       Date:  2015-12-28

Review 8.  Central Role of CEMIP in Tumorigenesis and Its Potential as Therapeutic Target.

Authors:  Li Li; Lin-Hai Yan; Shwetha Manoj; Ying Li; Lu Lu
Journal:  J Cancer       Date:  2017-07-20       Impact factor: 4.207

Review 9.  Potential Therapeutic Targets in Uterine Sarcomas.

Authors:  Tine Cuppens; Sandra Tuyaerts; Frédéric Amant
Journal:  Sarcoma       Date:  2015-10-21

10.  Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization.

Authors:  Chunxia Liu; Dongliang Li; Jinfang Jiang; Jianming Hu; Wei Zhang; Yunzhao Chen; Xiaobin Cui; Yan Qi; Hong Zou; WenJie Zhang; Feng Li
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.